Search - tctmd.com

Displaying 321 - 340 of 1146

Sort: Relevancy | Date

News Daily News

Statin-Intolerant Patients Have Significantly Worse Prognosis After MI

Michael O'Riordan

March 13, 2017

News Conference News ACC 2017

Low HDL Cholesterol Common in Young MI Patients, With Young Women Faring Worse Long-Term

Michael O'Riordan

March 10, 2017

News Conference News ACC 2017

Erectile Dysfunction Meds Linked to Fewer Death and HF Hospitalizations After MI

L.A. McKeown

March 09, 2017

News Daily News

DESolve Bioresorbable Stent Compares Well With Absorb, but Longer Follow-up Needed

Michael O'Riordan

February 16, 2017

News Daily News

First High-Sensitivity Troponin Assay Finally Comes to the United States

Todd Neale

January 24, 2017

News Daily News

Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy

Michael O'Riordan

January 18, 2017

News Daily News

HIV-Positive Patients Face Elevated Rate of Type 2 MI

Caitlin E. Cox

January 12, 2017

News Daily News

Noncardiac Chest Pain After Acute MI Common and ‘Just as Scary’: Why Cardiologists Should Care

Shelley Wood

January 12, 2017

News Features

Be It Resolved: Lifestyle Changes for Patients Needing Cardiac Rehab May Be a Life or Death Matter

Michael O'Riordan

January 10, 2017

News Daily News

Pain Sensitivity May Play Role in Unrecognized Myocardial Infarction

Leah Lawrence

December 27, 2016

News Daily News

Smoking and Acute MI: The Younger the Patient, the Higher the Risk

L.A. McKeown

December 02, 2016

News Conference News AHA 2016

PCI at Centers Without Surgical Backup ‘Probably OK,’ Nationwide Data Suggests

Yael L. Maxwell

November 16, 2016

AEGIS-I Trial: The Safety and Tolerability of CSL112

Presentation AHA 2016

The Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Human ApoA-I, After Acute Myocardial Infarction: The ApoA-I Event reducingG in Ischemic Syndromes I Trial (AEGIS-I)

Presenter: Michael Gibson

November 15, 2016

News Industry News TCT 2016

Study Finds No Long-Term Clinical Benefit to Routine Follow-Up Coronary Angiography After PCI

November 01, 2016

News Industry News TCT 2016

Dedicated Stent Study Conducted in Women and Minority Assesses Risks of Adverse Cardiovascular Events Following Coronary Stent Procedures

November 01, 2016

News Conference News TCT 2016

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

Michael O'Riordan

October 30, 2016

News Conference News TCT 2016

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

Todd Neale

October 29, 2016

News Daily News

STEMI Patients Far From PCI Centers Fare Well With Pharmacoinvasive Strategy

L.A. McKeown

October 05, 2016

News Daily News

No Differences Between Bivalirudin, Unfractionated Heparin in ACS Patients With or Without ST Elevation: MATRIX

Shelley Wood

October 03, 2016

News Daily News

Heavy Burden of Residual Thrombus After Thrombectomy Signals Worse Primary PCI Results

Todd Neale

October 03, 2016

Advertisement

Statin-Intolerant Patients Have Significantly Worse Prognosis After MI

Low HDL Cholesterol Common in Young MI Patients, With Young Women Faring Worse Long-Term

Erectile Dysfunction Meds Linked to Fewer Death and HF Hospitalizations After MI

DESolve Bioresorbable Stent Compares Well With Absorb, but Longer Follow-up Needed

First High-Sensitivity Troponin Assay Finally Comes to the United States

Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy

HIV-Positive Patients Face Elevated Rate of Type 2 MI

Noncardiac Chest Pain After Acute MI Common and ‘Just as Scary’: Why Cardiologists Should Care

Be It Resolved: Lifestyle Changes for Patients Needing Cardiac Rehab May Be a Life or Death Matter

Pain Sensitivity May Play Role in Unrecognized Myocardial Infarction

Smoking and Acute MI: The Younger the Patient, the Higher the Risk

PCI at Centers Without Surgical Backup ‘Probably OK,’ Nationwide Data Suggests

The Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Human ApoA-I, After Acute Myocardial Infarction: The ApoA-I Event reducingG in Ischemic Syndromes I Trial (AEGIS-I)

Study Finds No Long-Term Clinical Benefit to Routine Follow-Up Coronary Angiography After PCI

Dedicated Stent Study Conducted in Women and Minority Assesses Risks of Adverse Cardiovascular Events Following Coronary Stent Procedures

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

STEMI Patients Far From PCI Centers Fare Well With Pharmacoinvasive Strategy

No Differences Between Bivalirudin, Unfractionated Heparin in ACS Patients With or Without ST Elevation: MATRIX

Heavy Burden of Residual Thrombus After Thrombectomy Signals Worse Primary PCI Results

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content